Name: | Description: | Size: | Format: | |
---|---|---|---|---|
849.91 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Background and aims: Peripheral arterial disease (PAD) and venous thromboembolism (VTE) are vascular
traits sharing common modifiable and non-modifiable risk factors. These vascular pathologies have
known nuclear-encoded genetic risk factors and the mitochondrial DNA may account for part of the
missing heritability. To determine if PAD and VTE have a dual genetic control (mitochondrial and nu clear), we hereby investigated the association of mitochondrial DNA polymorphisms and haplogroups
with these vascular traits.
Methods: The association of mitochondrial single nucleotide polymorphisms (mtSNPs) and haplogroups
was tested in 1652 PAD cases and 1629 controls from the eMERGE PAD genome-wide association study
(GWAS), and 1241 VTE cases and 1278 controls from the GENEVA GWAS of venous thrombosis (dbGaP
accession numbers phs000203.v1.p1 and phs000289.v2.p1, respectively).
Results: 66 and 72 mtSNPs passed quality control filters and were tested for association with PAD and
VTE, respectively. Significant evidence of population stratification could not be detected in both datasets.
Three mtSNPs (m.477T > C, m.9667A > G, and m.10915T > C) were nominally associated
(3.01 10 3 pa 3.96 10 2
) with PAD in the logistic regression adjusted for confounding factors, and
m.11914G > A was nominally associated (pa ¼ 4.14 10 2
) with VTE. None of the nine major mito chondrial haplogroups were associated with either PAD or VTE.
Conclusion: Unlike other vascular diseases such as stroke and diabetes, these results suggest that com mon mitochondrial variants individually or in combination do not play a major role in PAD and VTE
susceptibility.
Description
Keywords
Peripheral arterial disease Venous thromboembolism Mitochondrial genome Genetic association study . Faculdade de Ciências da Vida
Citation
Abrantes, P., Rosa, A., Francisco, V., Sousa, I., Xavier, J. M., & Oliveira, S. A. (2016). Mitochondrial genome association study with peripheral arterial disease and venous thromboembolism. Atherosclerosis, 252, 97-105. https://doi.org/10.1016/j.atherosclerosis.2016.07.920
Publisher
Elsevier